Virtu Financial LLC Maxcyte, Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$2.6 - $5.24 $39,418 - $79,443	15,161 New	15,161 $71,000
Q3 2022 Nov 07, 2022	BUY	$4.52 - $6.51 $32,277 - $46,487	7,141 Added 4.79%	156,158 $1.02 Million
Q2 2022 Aug 09, 2022	SELL	$3.59 - $6.81 $7,686 - $14,580	-2,141 Reduced 1.42%	149,017 $705,000
Q1 2022 May 17, 2022	SELL	$5.26 - $10.84 $26,552 - $54,720	-5,048 Reduced 3.23%	151,158 $1.06 Million
Q4 2021 Feb 17, 2022	BUY	$8.87 - $12.94 $60,564 - $88,354	6,828 Added 4.57%	156,206 $1.59 Million
Q3 2021 Nov 12, 2021	BUY	$12.21 - $17.2 $1.82 Million - $2.57 Million	149,378 New	149,378 $1.82 Million

124

65.6M

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $447M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.